- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PFE
Recent news which mentions PFE
Pfizer's Options: A Look at What the Big Money is Thinking
January 28, 2025
Tickers
PFE
From Benzinga
I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One.
January 28, 2025
From Motley Fool
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
January 28, 2025
From Benzinga
Pfizer's Conditionally Approved Braftovi Combo Therapy Regime Shows Improved Response In Colorectal Cancer Patients
January 27, 2025
From Benzinga
What's Going On With Pfizer Stock Monday?
January 27, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2025
From Benzinga
JD Vance: 'Prices Are Going To Come Down, But It's Going To Take Time,' As Trump's Energy Policies Start To Take Effect
January 27, 2025
From Benzinga
Financial Crime Weekly: Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations, SEC Creates Crypto Task Force
January 26, 2025
From Benzinga
Have $500? 2 High-Yield Dividend Stocks to Buy Right Now
January 26, 2025
From Motley Fool
Got $100? This Top Dividend ETF Is a No-Brainer Buy Right Now.
January 25, 2025
From Motley Fool
From Motley Fool
My Top 5 Stocks to Buy in Early 2025
January 23, 2025
From Motley Fool
3 Dirt-Cheap Stocks to Buy in a Market That's Priced for Perfection
January 22, 2025
From Motley Fool
Legal Marijuana Linked To Drop In Anxiety Medications: What It Means For Pharma Giants
January 21, 2025
From Benzinga
Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever
January 21, 2025
From Motley Fool
3 Subtle Investing Mistakes I Won't Repeat in 2025 And Beyond
January 20, 2025
From Motley Fool
Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,000 in Passive Income in 2025
January 20, 2025
From Motley Fool
The Smartest Dividend Stocks to Buy With $100 Right Now
January 19, 2025
From Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
January 18, 2025
From Motley Fool
Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks
January 18, 2025
From Motley Fool
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
From Benzinga
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company
January 17, 2025
From Benzinga
Got $200? 2 Dividend Stocks to Buy and Hold Forever
January 15, 2025
From Motley Fool
From Benzinga
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty
January 14, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 14, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.